TY  - JOUR
AU  - Arca-Suárez, Jorge
AU  - Fraile-Ribot, Pablo
AU  - Vázquez-Ucha, Juan Carlos
AU  - Cabot, Gabriel
AU  - Martínez-Guitián, Marta
AU  - Lence, Emilio
AU  - González-Bello, Concepción
AU  - Beceiro, Alejandro
AU  - Rodríguez-Iglesias, Manuel
AU  - Galán-Sánchez, Fátima
AU  - Bou, Germán
AU  - Oliver, Antonio
PY  - 2019
DO  - 10.1128/AAC.01110-19
UR  - http://hdl.handle.net/10668/14364
T2  - Antimicrobial agents and chemotherapy
AB  - Selection of extended-spectrum mutations in narrow-spectrum oxacillinases (e.g., OXA-2 and OXA-10) is an emerging mechanism for development of in vivo resistance to ceftolozane-tazobactam and ceftazidime-avibactam in Pseudomonas aeruginosa Detection...
LA  - en
KW  - OXA
KW  - Pseudomonas aeruginosa
KW  - antimicrobial resistance
KW  - ceftazidime-avibactam
KW  - ceftolozane-tazobactam
KW  - class D beta-lactamase
KW  - Aged, 80 and over
KW  - Anti-Bacterial Agents
KW  - Azabicyclo Compounds
KW  - Ceftazidime
KW  - Cephalosporins
KW  - Drug Combinations
KW  - Humans
KW  - Kinetics
KW  - Microbial Sensitivity Tests
KW  - Pseudomonas Infections
KW  - Pseudomonas aeruginosa
KW  - Tazobactam
KW  - Whole Genome Sequencing
KW  - beta-Lactamases
TI  - Challenging Antimicrobial Susceptibility and Evolution of Resistance (OXA-681) during Treatment of a Long-Term Nosocomial Infection Caused by a Pseudomonas aeruginosa ST175 Clone.
TY  - research article
VL  - 63
ER  -